Can the form be signed electronically?

Yes. Electronic signatures are legally valid under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA laws, provided intent, consent, attribution, and record retention requirements are met; certain exceptions apply (wills, some court filings).

What signature methods are acceptable?

Acceptable methods include typed names, drawn signatures on touch devices, scanned signatures, and PKI-based digital signatures. Choose a method appropriate for the study risk and regulatory requirements such as 21 CFR Part 11 for FDA-regulated records.

Do I need a witness or notary?

Most clinical consent forms do not require notarization; witness or notary requirements depend on state law and sponsor or institutional policies. Confirm with your IRB and local notary commission before adding witness or notarization steps to the form.

How long must I keep completed forms?

Retention varies by record type and regulator: HIPAA requires 6 years (45 CFR §164.530(j)), IRS rules often require 3 years for tax records (IRC §6501(a)), and sponsors may require longer retention; follow institutional and sponsor guidance.

Can I use RON for consent?

Remote online notarization may be acceptable in states that permit RON, subject to identity proofing and audio‑video recording requirements. Verify state notary rules and IRB policies; retain RON session records per state retention rules.

What if a field is filled incorrectly?

Document corrections per sponsor and IRB guidance: short mistakes may be initialed and dated by the signer and witness; substantial changes often require reconsent. Maintain an audit trail showing who made changes and why for regulatory inspection.

Electronic Signature
Templates
Healthcare
Healthcare Clinical Trial Form

Healthcare Clinical Trial Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare Clinical Trial Form

Study Information

Study ID: Study Title:

Principal Investigator:

Study Site:

Study Coordinator (Name & Contact):

Participant Information

Full legal name Date of birth Gender (select all that apply)

Female Male Non-binary/Other Prefer not to answer

Residential address Primary telephone Emergency contact

Insurance and Billing

Primary insurer Policy number Group number Subscriber name (if different)

Medical History

Current medications (include dose and frequency) Known allergies (drug, food, environmental) Prior surgeries and hospitalizations (include dates) Chronic medical conditions

Do you have any implanted medical device (pacemaker, neurostimulator, etc.)? Yes No

Are you currently pregnant or breastfeeding? Yes No

Consent to Participate — Required Statements

I authorize my participation in the clinical trial described above. I understand that the purpose, procedures, anticipated benefits, and foreseeable risks of the study have been explained to me and that I have had the opportunity to ask questions. I acknowledge that participation is voluntary and I may withdraw at any time without penalty or loss of benefits to which I am otherwise entitled.

I understand the specific procedures required by this study may include: study visits, blood draws, imaging, administration of study medication or device, collection of biological specimens, and completion of questionnaires. Possible risks and side effects, both known and unknown, have been described to me. I understand that additional risks may occur and that no guarantee has been made regarding results or benefit to me.

I understand any treatment or tests performed as part of the study may result in charges to my health insurer or me unless otherwise specified by the study. I have been informed whether compensation or treatment will be available to me in the event of a research-related injury, and I understand my rights and procedures for reporting such events.

I consent to the collection, use, and disclosure of my health information for purposes of the study, data monitoring, regulatory compliance, and publication of aggregated results. Identifiable personal information will be handled in accordance with applicable privacy protections described below.

I have been informed of alternatives to participation, including not participating and receiving standard medical care. I understand that participation does not guarantee therapeutic benefit and that I may be assigned to a control or placebo group if the protocol includes such arms.

Participant initial to acknowledge understanding of risks and voluntary nature

HIPAA Authorization and Data Use

I authorize the use and disclosure of my Protected Health Information (PHI) for purposes of this research, monitoring, testing, audit, and regulatory review. PHI may include medical records, lab results, images, and study-specific information. The study team may share PHI with the sponsor, institutional review board, regulatory authorities, and service providers performing functions related to the study.

I understand my information will be held confidential to the extent required by law, but absolute confidentiality cannot be guaranteed. Identifiers will be removed for data analysis and publications whenever practicable. I may revoke this authorization in writing at any time, except to the extent that action has been taken in reliance on it.

Authorization expiration (date or event):

I acknowledge receipt of the information above and consent to data use

I authorize and acknowledge the HIPAA data use terms and consent to release of PHI as described.

Specimens, Future Use, and Genetic Testing

I consent to the collection and storage of biological specimens (blood, tissue, saliva) for analysis related to this protocol. I understand specimens may be stored for future research, including genetic testing, and may be de-identified before use. I understand I may decline future use of my specimens without affecting participation in the current study.

I consent to future use of stored specimens for research as described.

Compensation and Treatment for Injury

The sponsor or institution's policy regarding compensation for research-related injury has been explained to me. I understand procedures for reporting an adverse event and where to seek medical treatment in the event of an injury related to participation in this study.

I have had the opportunity to ask questions and have received answers. I understand I can contact the study coordinator or principal investigator with further questions regarding my rights, the study, or adverse events.

Participant questions or concerns contact (name/phone)

Certification and Acknowledgment

By signing below I certify that the information I have provided is accurate to the best of my knowledge. I consent to participate under the terms and conditions described in this form and as explained by study staff. I understand that signing this form constitutes informed consent and does not waive any of my legal rights.

Participant Printed Name:

Signature:

Date:

If signed by legal guardian, Relationship:

What the Healthcare Clinical Trial Form Is

Healthcare Clinical Trial Form is a standardized document used to capture participant consent, eligibility data, medical history, and study-specific information required by institutional review boards (IRBs) and sponsors. It combines demographic fields, informed consent language, procedure descriptions, risks and benefits, contact information, and signature blocks to document voluntary participation. The form supports regulatory reporting, safety monitoring, and audit readiness by ensuring consistent data capture across sites. Proper completion reduces protocol deviations and helps meet HIPAA, FDA, and IRB documentation expectations for clinical research in the United States.

Why a Standardized Clinical Trial Form Matters

Use the Healthcare Clinical Trial Form to document informed consent, collect essential participant data, and provide an audit trail for regulators. Standardized forms improve data quality, support IRB reviews, and help maintain HIPAA-compliant records across multi-site studies.

Who Prepares and Signs This Form

Typical users who prepare or sign the Healthcare Clinical Trial Form include research staff, investigators, and institutional review boards.

Principal investigators and sub-investigators responsible for protocol oversight and participant safety.
Clinical research coordinators who enroll participants and manage source documentation at study sites.
IRB administrators and sponsors reviewing consent language, eligibility criteria, and regulatory compliance.

Completed forms are also reviewed by monitors and auditors during inspections, data reviews, and safety reporting.

Step-by-Step: Completing the Form at the Site

Follow these steps to complete the Healthcare Clinical Trial Form accurately and in compliance with IRB requirements.

01

Prepare: Confirm protocol version and collect site-specific study IDs.
02

Verify: Check participant identity and eligibility criteria against source documents.
03

Complete: Fill demographic, medical history, and consent version fields.
04

Sign: Participant signs, dates, and initial required sections.

Key Data Elements to Protect

Participant ID: Unique study identifier, no PHI.

Full Name: As on government ID.

DOB: Enter as MM/DD/YYYY format.

Medical History: List allergies and current medications.

Consent Version: Record version and effective date.

Signature: Signed and dated by participant.

Penalties and Risks of Incorrect or Incomplete Forms

Missing Consent: Regulatory noncompliance risk.

Incorrect DOB: Eligibility disputes possible.

Unsigned Pages: Void consent; protocol deviations.

Mismatched Names: Payment or TIN issues.

Late Reporting: FDA or IRB findings.

Data Breach: HIPAA penalties and reporting.

Common Pitfalls to Avoid

Incomplete medical history fields lead to screening errors, delayed enrollment, and additional site queries that extend study timelines.
Using inconsistent consent versions across sites causes regulatory findings and may require reconsent of affected participants.
Failing to verify identity or missing signature dates can invalidate consent and trigger IRB noncompliance notices.
Poorly labeled source documents increase audit time and raise questions during safety or data verification reviews.

Who Signs and Why

Principal Investigator

The Principal Investigator oversees study conduct, ensures consent documents meet regulatory requirements, and certifies participant eligibility. They must confirm that the Healthcare Clinical Trial Form was completed accurately and retained according to institutional policies before any study-related procedures begin.

Sponsor Clinical Rep

The Sponsor Clinical Representative reviews submitted forms for completeness, reconciles discrepancies, and reports adverse events per the protocol. They coordinate with sites and the IRB to address missing information and support regulatory inspections and monitoring visits.

Typical Submission and Review Flow

Typical submission flow shows how the form moves from site completion to sponsor review and archived records.

Site Entry: Coordinator completes form and uploads to study system.
IRB Review: IRB checks consent language and compliance notes.
Sponsor Review: Sponsor clinical team verifies completeness and adverse events.
Archive: Signed forms stored securely with audit trail.

Essential Sections to Include on the Form

Essential sections of the Healthcare Clinical Trial Form ensure informed consent, eligibility verification, and traceable signatures for regulatory review and auditing.

Informed Consent

Clearly worded consent text explains study purpose, procedures, foreseeable risks, and benefits; it must include participant rights, the voluntary nature of participation, withdrawal details, and contact information for questions.

Eligibility

Structured eligibility checklist captures inclusion and exclusion criteria, relevant lab values, prior treatments, and protocol-specific thresholds to support screening decisions and to document rationale for enrollment or screen failure.

Medical History

Targeted medical history fields collect diagnoses, allergies, current medications, and prior adverse events; accurate entries are required for safety assessments and for identifying potential contraindications to study procedures.

Procedures

Describe scheduled study procedures, visit windows, sample collections, and any required participant preparations; tie procedures directly to consented activities to avoid protocol deviations during conduct.

Contact Info

Provide sponsor and site contact details for reporting adverse events, participant questions, and emergency contact numbers; accurate contacts shorten response times and assist IRB communications.

Signatures

Include participant signature, date, and witness or investigator signatures as required; record the consent version, signer role, and method of signature (wet or electronic) for audit purposes.

Suggested Digital Workflow Settings

Configure the digital workflow to automate routing, authentication, and record retention for clinical trial forms.

Field	Configuration
Authentication Method	Email link or SMS one-time passcode
Routing Order	Sequential signer order with reminders
Retention Policy	Automatic archival and exportable audit log
Field Types	Text, date, checkbox, dropdown, signature

Platform Capabilities to Verify

Ensure the signing platform meets authentication, encryption, and integration requirements used by clinical operations and reporting.

Authentication: Email, SMS, or KBA options.
Encryption: TLS 1.2/1.3 and AES-256 at rest.
Integrations: Connects with EHRs and CTMS.

Key Deadlines and Time-Critical Actions

Key regulatory and operational deadlines for clinical trial forms include submission, reporting, and retention milestones.

IRB Submission:

Submit consent forms with protocol application before enrollment begins.

Initial Enrollment:

Complete consent and eligibility prior to first study procedure.

Adverse Event Reporting:

Report serious events per protocol and FDA timelines.

Data Lock:

Ensure forms are finalized before database lock and analysis.

Record Retention:

Retain signed forms per institutional and federal retention policies.

Milestone Timeline from Approval to Closeout

Sequential milestones show the lifecycle of a clinical trial form from approval through closeout and archiving.

01

Protocol Approval

IRB approves protocol and consent version; start enrollment afterward.

02

Site Initiation

Sites trained and authorized to enroll after documentation is in place.

03

Interim Review

Periodic monitoring and safety review may prompt form updates.

04

Study Closeout

Finalize records, resolve queries, and archive signed forms.

E-signature Pricing and Feature Comparison

Compare typical starting prices and core features for e-signature vendors commonly used to process clinical trial forms; signNow is listed first per vendor order conventions.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	Yes
Audit Trail	Yes	Yes	Yes	Yes	Yes
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

Frequently Asked Questions and Troubleshooting

Answers to common questions about completing, signing, and storing the Healthcare Clinical Trial Form securely.

Need help? Contact support

Can the form be signed electronically?
Yes. Electronic signatures are legally valid under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA laws, provided intent, consent, attribution, and record retention requirements are met; certain exceptions apply (wills, some court filings).
What signature methods are acceptable?
Acceptable methods include typed names, drawn signatures on touch devices, scanned signatures, and PKI-based digital signatures. Choose a method appropriate for the study risk and regulatory requirements such as 21 CFR Part 11 for FDA-regulated records.
Do I need a witness or notary?
Most clinical consent forms do not require notarization; witness or notary requirements depend on state law and sponsor or institutional policies. Confirm with your IRB and local notary commission before adding witness or notarization steps to the form.
How long must I keep completed forms?
Retention varies by record type and regulator: HIPAA requires 6 years (45 CFR §164.530(j)), IRS rules often require 3 years for tax records (IRC §6501(a)), and sponsors may require longer retention; follow institutional and sponsor guidance.
Can I use RON for consent?
Remote online notarization may be acceptable in states that permit RON, subject to identity proofing and audio‑video recording requirements. Verify state notary rules and IRB policies; retain RON session records per state retention rules.
What if a field is filled incorrectly?
Document corrections per sponsor and IRB guidance: short mistakes may be initialed and dated by the signer and witness; substantial changes often require reconsent. Maintain an audit trail showing who made changes and why for regulatory inspection.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now